Guía para hablar sobre el Coronavirus de manera sencilla, clara y tranquilizadora
Este documento tiene el propósito de ser ampliamente difundido entre las comunidades, familias, trabajadores del ámbito de la salud y la educación, así como todos los adultos responsables de niños y niñas pequ...eños.
Pretende servir como una guía para hablar sobre el Coronavirus, COVID-19, de manera sencilla, clara y tranquilizadora, a la vez que permite abordar las emociones que puedan estar sintiendo los niños y niñas en la primera infancia.
more
Each year, 33000 people die from an infection due to bacteria resistant to antibiotics. The burden of infections with bacteria resistant to antibiotics on the European population is comparable to that of influenza, tuberculosis and HIV/AIDS combined.
Цель: оценить этиологическую структуру симптоматической эпилепсии, возрастную структуру периода манифестации заболевания, среднюю длительность латентного пери...да среди детей с различным характером повреждений, зависимость частоты приступов от характера повреждения. Материал и методы. Изучались 180 медицинских карт пациентов, имевших симптоматическую и криптогенную формы заболевания. Анализ заключался в оценке анамнестических данных, параметров ЭЭГ-исследований и нейровизуализации. Результаты. Установлено преобладание гипоксически-ишемической энцефалопатии в этиологической структуре заболевания. Возраст манифестации чаще приходился на период от года до 3 лет. Наиболее частой локализаци-
ей эпилептогенного очага явилась область височной и лобной доли. Наиболее длительный латентный период отмечен при ЧМТ, а наиболее короткий — при нейроинфекциях и последствиях внутриутробных инфекций. Заключение. Симптоматическая эпилепсия у детей является многофакторным заболеванием, течение и проявление которого в значительной мере зависят от инициального повреждения, вызвавшего данную патологию.
http://www.ssmj.ru/system/files/2014_02_318-319.pdf
more
Protecting Migrants or Reversing Migration? COVID-19 and the risks of a protracted crisis in Latin America
Меры по борьбе с эпидемией
Текущая актуализация мер по борьбе с КОВИД-19 в СНГ
Information bulletins on measures to combat coronavirus in CIS countries
Health workers involved in deployment and implementation of COVID-19 vaccination require vaccine-specific knowledge to ensure safe and efficient vaccine delivery. This training provides key information about COVID-19 vaccines through short instructional videos, vaccine explainers, job aids, topic br...iefings, and downloadable presentations. It builds on the COVID-19 vaccination training for health workers and the Orientation to National Deployment and Vaccination Planning for COVID-19.
Please note that further videos and resources concerning other vaccines will be added as they receive emergency use listing (EUL) or prequalification. Available in different languages
more
The European Union Agency for Fundamental Rights (FRA) collected evidence through field missions and from other sources reporting on the situation in March, May and October 2022.
In parallel, it launched a large-scale online survey of those fleeing Ukraine. This aimed to gather personal experiences... of their journey to, arrival in and settling in the EU. The survey covered displaced people, including many children, in the 10 EU Member States hosting large numbers of people registered for temporary protection.
more
2-Day Orientation training Orientation Training, 1 Febr. 2021
Community Health Workers (CHWs) are an essential part of the Partnership to Accelerate COVID-19 Testing (PACT) Initiative • Africa CDC set up PACT to drive forward the Africa Union Joint Continental Strategy for COVID-19
Available in ...English, French and Arabic
more
On the 9 February 2021, Africa CDC convened a special session of the Africa Task Force for COVID-19 to review existing data and evidence and recommend
В этом дискуссионном документе излагаются факты, касающиеся передозировки опиоидов, мер, которые могут быть приняты в целях предупреждения и лечения (коррекции) п...редозировки опиоидов, и указываются области, требующие дальнейшего исследования.
more
Revised working paper following AVAREF meeting February 2019.
WHO has published a roadmap aiming to coordinate partners’ actions and contributions to the licensing and roll-out of Merck’s Ebola vaccine (VSV-ZEBOV) in African countries. The vaccine was developed during the West Africa Ebola epi...demic of 2014-2016, during which more than 11 000 people lost their lives to the disease. The vaccine was tested in European and African countries at the time and is currently used under an “expanded access” protocol in the Democratic Republic of Congo.
WHO will expedite prequalification and licensing of the vaccine for use in countries at risk of Ebola outbreaks and will coordinate work between those countries’ regulatory authorities and the European Medicines Agency and the US Food and Drug Administration.
more
This strategic document is relevant to the diverse contexts that exist across the WHO European Region, and to countries implementing a wide range of national and subnational responses. The strategy is flexible and adaptable to national and subnational contexts and guides countries in rapidly bringin...g COVID-19 cases under control, and in preparing for a phased transition from a widespread transmission to a steady state of low-level or no transmission.
more
Epidemiology, Control, and Financing
Good Practices in Mental Health & Well-being
An overview of COVID-19 Vaccine AstraZeneca and why it is authorised in the EU. Available in 22 languages
18 Febr. 2021
Key Considerations
This brief focuses on cross-border movement in Eastern and Southern Africa (ESA) and its implications for development of risk communication and community engagement (RCCE) strategies aimed at preventing transmission of COVID-19 in the ESA region. Given the extensive risk of cross...-border transmission of the virus and the imminent reopening of borders, such strategies are essential to containment efforts
more